← Back to all trials
Not Yet Recruiting
NCT05627388
Feasibility Study of At-Home EEG Monitoring for Hypersomnia
Conditions: Hypersomnia, Narcolepsy
Sex: All
Ages: 6 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 20
Sponsor: Kaiser Permanente
Summary
The central hypothesis is that home EEG monitoring (Dream 3 wearable) can be feasibly utilized for data capture of continuous sleep and wake measurements for the diagnostic evaluation and treatment monitoring of hypersomnia.
Eligibility Criteria
Inclusion Criteria:Patients must be a Kaiser Permanente memberPatients must be ≥ 6 years old.Patients must have an indication for Multiple Sleep Latency Test for a diagnosis of hypersomniaPatients are able/willing to consent and willing to undergo the electrophysiological routine assessments described in the protocolPatients do not meet any exclusion criteriaExclusion Criteria:Patients under 6 years old.If a patient is taking a wake promoting medication and is unsafe to withdraw the medication during the 2 weeks prior to the in-lab Polysomnography/Multiple Sleep Latency studyPatients suffering from mental and/or physical disorders that could interfere with the study protocol or the interpretation of the results (exclusion based on clinical judgment)Shift workers or patients working unusual hours will be excludedPatients not able to sign an informed consent form
Source: ClinicalTrials.gov (NCT05627388). StuddyBuddy aggregates publicly available trial information.